company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3994000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3994000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,94000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,44000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1478000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2378000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2378000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-6000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2397000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5406000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5406000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,92000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1208000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,50000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4056000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4056000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,29668000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2387000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32049000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32049000.0
Immune Design Corp,IMDZ,,0001437786,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27956000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8223000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8223000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2898000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,123000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5141000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5141000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-171000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-171000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-171000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 16:59:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5371000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6126000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6126000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1706000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1399000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5758000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5758000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1197000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1197000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1197000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7013000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6682000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6682000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,55000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,551000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4191000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1885000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1885000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-74000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-74000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,1368000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57826000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8150000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,67344000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,67344000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,65385000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13120000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13120000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,466000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4708000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7885000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7885000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-153000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-153000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-153000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4000.0
Immune Design Corp,IMDZ,,0001437786,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8034000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9406000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9406000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1231000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6818000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14941000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14941000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-132000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-132000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-132000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-128000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-51000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-51000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:42:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15124000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10517000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10517000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1813000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1928000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6717000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6717000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-74000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-74000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,128000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,75431000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,75559000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,75559000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68768000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7407000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7407000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1407000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2666000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8600000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8600000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-102000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-102000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,194000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,194000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,194000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8508000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12115000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12115000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1846000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2682000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7543000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7543000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-119000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-119000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-119000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,93000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,93000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,93000.0
Immune Design Corp,IMDZ,,0001437786,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7569000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12294000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12294000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,76000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-48000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2335000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2209000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12140000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12140000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46000000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46019000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46019000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:27:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-58159000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14347000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14347000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,75000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,20000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2246000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3709000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8297000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8297000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2000000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3965000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3965000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,101000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,101000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,101000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4231000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12443000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12443000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,77000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2326000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-880000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10922000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10922000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17000000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17000000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30847000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30847000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30847000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19903000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14446000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14446000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,76000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,156000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2376000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7457000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4381000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4381000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37288000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17000000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20345000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20345000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-494000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-494000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-494000.0
Immune Design Corp,IMDZ,,0001437786,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25220000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12620000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12620000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,26000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2247000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-913000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11181000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11181000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-202000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8999000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-201000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-201000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,286000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,286000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,286000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 08:36:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11096000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13846000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13846000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,30000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2205000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2861000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8660000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8660000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2999000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19000000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15942000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15942000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,111000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,111000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,111000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7393000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13416000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13416000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,87000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-11000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2149000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5988000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17179000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17179000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-83000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11966000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22000000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9951000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9951000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,286000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,286000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,286000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6942000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11980000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11980000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,95000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-71000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2032000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,85000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9839000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9839000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-84000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47647000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-32731000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-32731000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,86655000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86655000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86655000.0
Immune Design Corp,IMDZ,,0001437786,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44085000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13300000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13300000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,84000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-150000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2738000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5755000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16383000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16383000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-204000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10921000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21000000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9875000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9875000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,226000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,226000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,226000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q1,2018-01-01,2018-03-31,2018-05-03 08:36:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6282000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13808000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13808000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,102000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-142000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1511000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1418000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10919000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10919000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8915000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21000000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12046000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12046000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,131000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,131000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,131000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1258000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14049000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14049000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,82000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-139000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1803000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-663000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12966000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12966000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8903000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17000000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8071000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8071000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4895000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11398000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11398000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-121000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5946000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27000000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20933000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20933000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-129000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-129000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-129000.0
Immune Design Corp,IMDZ,,0001437786,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9406000.0
